Company Description
Ypsomed Holding AG. The Group's principal activities are to develop, manufacture and sells custom-made injection pens for the treatment of diabetes, growth disorders or infertility, as well as for further therapeutic areas. The products of the Group ...
Related Business Topics
Breaking News
Reuters - November 02, 2009 11:40 PM
Group (in SFR millions unless otherwise stated) Latest Year Change in Ago percent Sales 125.6 138.2 -9.1 Operating profit 6.8 16.5 -58.8 Net profit/loss 6.6 ...
Forbes.com - November 02, 2009 11:29 PM
Group (in SFR millions unless otherwise stated) Latest Year Change in Ago percent Sales 125.6 138.2 -9.1 Operating profit 6.8 16.5 -58.8 Net profit/loss 6.6 13.6 ...
Reuters UK - November 02, 2009 11:16 PM
Group (in SFR millions unless otherwise stated) Latest Year Change in Ago percent Sales 125.6 138.2 -9.1 Operating profit 6.8 16.5 -58.8 Net profit/loss 6.6 13.6 -51.5 (Reporting by Jaroslaw Wojtala in Gdynia, Poland) © Thomson Reuters 2009 All rights ...
